Copyright © 2000 by the European Society of Cardiology.
Editorial
Long-term benefit of primary angioplasty compared to thrombolytic therapy for acute myocardial infarction
Department of Cardiology, Hospital De Weezenlanden, Zwolle, The Netherlands
References
- Eur Heart J. 1996;17:4363
[Free Full Text] - Weaver WD, Simes RJ, Betriu A. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative overview. JAMA. 1997;278:20932098[Abstract]
- Zijlstra F, Hoorntje JCA, de Boer MJ. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 1999;341:14131419
[Abstract/Free Full Text] - Stone GW, Grines CL, Rothbaum D. Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the primary angioplasty in myocardial infarction (PAMI) trial. J Am Cardiol. 1997;29:901907
- Gibbons RJ, Holmes DR, Reeder GS, Bayley KR, Hopfenspirger MR, Gersh BJ. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med. 1993;328:685691
[Abstract/Free Full Text] - Lieu TA, Gurley RJ, Lundstrom RJ. Projected cost-effectiveness of primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 1997;30:17411750[Abstract]
- Van't Hof AWJ, Suryapranata H, de Boer MJ, Hoorntje JCA, Zijlstra F. Costs of stenting for acute myocardial infarction. Lancet. 1998;351:1817[ISI][Medline]
- Grines CL, Cox DA, Stone GW. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med. 1999;341:19491956
[Abstract/Free Full Text] - Kimmel SE, Berlin JA, Laskey WK. The relationship between coronary angioplasty procedure volume and major complications. JAMA. 1996;274:11371142
- Christian TF, O'Keefe JH, DeWood MA. Intercenter variability in outcome for patients treated with direct coronary angioplasty during acute myocardial infarction. Am Heart J. 1998;135:310317[CrossRef][ISI][Medline]
- Caputo RP, Ho KKL, Stoler RC. Effect of continuous quality improvement analysis on the delivery of primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol. 1997;79:11591164[CrossRef][ISI][Medline]
- Zijlstra F, de Boer MJ. Primary angioplasty for acute myocardial infarction, the Zwolle approach. Modern management of acute myocardial infarction. Semin Intervent Cardiol. 1999;4:5558[Medline]
- Zijlstra F, van't Hof AWJ, Liem AL, Hoorntje JCA, Suryapranata H, de Boer MJ. Transferring patients for primary angioplasty; a retrospective analysis of 104 selected high risk patients with acute myocardial infarction. Heart. 1997;78:333336
[Abstract/Free Full Text] - O'Neill WW, de Boer MJ, Gibbons RJ. Lessons from the pooled outcome of the Pami, Zwolle and Mayo Clinic randomized trials of primary angioplasty versus thrombolytic therapy of acute myocardial infarction. J Invasive Cardiol. 1998;10:4A10A
- Liem AL, van't Hof AWJ, Hoorntje JCA, de Boer MJ, Suryapranata H, Zijlstra F. Influence of treatment delay on infarct size and clinical outcome in patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol. 1998;32:629633
[Abstract/Free Full Text] - Verheugt FWA, Liem AL, Zijlstra F, Marsh RC, Veen G, Bronzwaer JGF. High dose bolus heparin as initial therapy before primary angioplasty for acute myocardial infarction: results of the heparin in early patency (HEAP) pilot study. J Am Coll Cardiol. 1998;31:289293
[Abstract/Free Full Text] - Ross AM, Coyne CS, Reiner JS. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction; the PACT trial. J Am Coll Cardiol. 1999;34:19541962
[Abstract/Free Full Text] - van den Merkhof LFM, Zijlstra F, Olsson H. Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty. Results of the glycoprotein receptor antagonist patency evaluation (Grape) pilot study. J Am Coll Cardiol. 1999;33:15281533
[Abstract/Free Full Text]
This article has been cited by other articles:
![]() |
F. Zijlstra, N. Ernst, M.-J. de Boer, E. Nibbering, H. Suryapranata, J. C. A. Hoorntje, J.-H. E. Dambrink, A. W. J. van't Hof, and F. W. A. Verheugt Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute st elevation myocardial infarction J. Am. Coll. Cardiol., June 5, 2002; 39(11): 1733 - 1737. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Zijlstra, A Patel, M Jones, C.L Grines, S Ellis, E Garcia, L Grinfeld, R.J Gibbons, E.E Ribeiro, F Ribichini, et al. Clinical characteristics and outcome of patients with early (<2h), intermediate (2-4h) and late (>4h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction Eur. Heart J., April 1, 2002; 23(7): 550 - 557. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zijlstra Does it matter where you go with an acute myocardial infarction? Eur. Heart J., October 1, 2001; 22(19): 1764 - 1766. [PDF] |
||||
![]() |
F. Zijlstra CORONARY DISEASE: Acute myocardial infarction: primary angioplasty Heart, June 1, 2001; 85(6): 705 - 709. [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


